Lynx1 Capital Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001910456

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2026 · 31 positions · Total reported value $646.09M · Top-10 concentration 97.9% · Updated 2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

Turnover: 30.3% · 6 new · 2 cut · 2 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -15.3% · vs SPY -17.4% · Prev Value $865.53M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -5.1% · vs SPY -7.2% · Latest Value $646.09M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Lynx1 Capital Management LP disclosed 31 equity positions with a combined reported value of $646.09M. The filing implies a focused portfolio: its ten largest positions account for 97.9% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were GHRS ($311.42M), CGEM ($137.59M), STOK ($101.30M). By sector, the heaviest allocations are Health Care 100.0%.

Versus the prior quarter, Lynx1 Capital Management LP opened 6 new positions, trimmed 2 and fully exited 2, a turnover rate of 30.3% of positions. The portfolio's overlap with the prior quarter was 76% of names.

The largest new positions opened in Q3 2026 were KZIA ($2.17M), SRZN ($643.60K), DARE ($495.44K).

Of the 2 positions fully exited versus the prior quarter, the largest were CGON ($2.23M), VYNE ($1.06M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • KZIA KAZIA THERAPEUTICS LTD · $2.17M
  • SRZN SURROZEN INC · $643.60K
  • DARE YARROW BIOSCIENCE INC · $495.44K
  • IMCR IMMUNOCORE HLDGS PLC · $433.15K
  • DYN DYNE THERAPEUTICS INC · $402.75K
  • PRME PRIME MEDICINE INC · $137.47K

Fully Exited (vs previous quarter)

  • CGON CG ONCOLOGY INC · prev qtr: $2.23M
  • VYNE YARROW BIOSCIENCES INC · prev qtr: $1.06M

Insider Transactions (Form 4)

Latest Lynx1 Capital Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-26 Buy Korro Bio, Inc. 25,124 $11.75 SEC filing
2026-10-23 Buy Korro Bio, Inc. 2,510 $12.11 SEC filing
2026-10-22 Buy Korro Bio, Inc. 40,000 $11.04 SEC filing
2026-10-22 Buy Korro Bio, Inc. 12,175 $9.68 SEC filing
2026-08-10 Buy Korro Bio, Inc. 1,462 $13.19 SEC filing
2026-08-06 Buy Korro Bio, Inc. 5,222 $11.40 SEC filing
2026-06-25 Buy Passage BIO, Inc. 50,055 $4.12 SEC filing

All insider transactions →

Fund Profile

Lynx1 Capital Management LP, based in Dorado, PR, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 31 positions worth $646.09M in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: DORADO, PR, United States
  • SEC registration: 801-127585 (status: Approved), registered 2023-04-05
  • Regulatory AUM (Form ADV): $626.68M as of 2026-10-07
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 1 hedge funds

Portfolio Structure

  • 31 positions · $646.09M reported value (Q3 2026)
  • Top 10 holdings = 97.9% of reported value
  • Largest position: GHRS (GH RESEARCH PLC) at 48.2%
  • Average position size: $20.84M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 6 new, 5 added, 2 reduced, 2 exited
  • 18 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 100.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 13.26M $311.42M 48.20%
48.20%
Hold
2 8.96M $137.59M 21.30%
21.30%
Hold
3 3.90M $101.30M 15.68%
15.68%
Reduce
4 7.53M $25.08M 3.88%
3.88%
Add
5 2.76M $17.27M 2.67%
2.67%
Add
6 472.61K $15.71M 2.43%
2.43%
Reduce
7 1.54M $15.31M 2.37%
Form 4 · 4 →
2.37%
Hold
8 875.33K $3.12M 0.48%
0.48%
Hold
9 673.76K $3.03M 0.47%
0.47%
Hold
10 1.56M $2.59M 0.40%
0.40%
Add
11 8.02M $2.52M 0.39%
0.39%
Hold
12 225.80K $2.17M 0.34%
0.34%
New
13 1.80M $1.94M 0.30%
0.30%
Hold
14 278.61K $1.77M 0.27%
0.27%
Add
15 20.00K $643.60K 0.10%
0.10%
New
16 71.26K $625.69K 0.10%
0.10%
Add
17 657.79K $606.68K 0.09%
0.09%
Hold
18 22.00K $495.44K 0.08%
0.08%
New
19 18.19K $453.94K 0.07%
0.07%
Hold
20 14.30K $433.15K 0.07%
0.07%
New
21 25.00K $402.75K 0.06%
0.06%
New
22 559.47K $332.21K 0.05%
0.05%
Hold
23 11.66K $240.97K 0.04%
0.04%
Hold
24 21.25K $228.81K 0.04%
0.04%
Hold
25 61.59K $219.87K 0.03%
0.03%
Hold
26 10.10K $154.83K 0.02%
0.02%
Hold
27 45.00K $137.47K 0.02%
0.02%
New
28 30.80K $113.34K 0.02%
0.02%
Hold
29 10.00K $91.00K 0.01%
0.01%
Hold
30 16.03K $89.76K 0.01%
0.01%
Hold
31 20.00K $1.20K 0.00%
0.00%
Hold

FAQ

What did Lynx1 Capital Management LP buy in 2026-Q3?

In its 2026-Q3 13F filing, Lynx1 Capital Management LP reported 31 equity positions worth $646.09M in aggregate; its largest disclosed positions were GHRS ($311.42M), CGEM ($137.59M), STOK ($101.30M).

How large is Lynx1 Capital Management LP's portfolio?

Lynx1 Capital Management LP reported $646.09M of long equity holdings across 31 positions as of 2026-Q3. Top-10 holdings account for 97.9% of reported value.

What is Lynx1 Capital Management LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/lynx1-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →